Fatty acids and the immune system: from basic science to clinical applications
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Over the last 25 years, the effects of fatty acids on the immune system have been characterized using in vitro, animal and human studies. Advances in fatty acid biochemistry and molecular techniques have recently suggested new mechanisms by which fatty acids could potentially modify immune responses, including modification of the organization of cellular lipids and interaction with nuclear receptors. Possibilities for the clinical applications of n-3 PUFA are now developing. The present review focuses on the hypothesis that the anti-inflammatory properties of n-3 PUFA in the arterial wall may contribute to the protective effects of n-3 PUFA in CVD, as suggested by epidemiological and secondary prevention studies. Studies are just beginning to show that dietary n-3 PUFA can be incorporated into plaque lipid in human subjects, where they may influence the morphology and stability of the atherosclerotic lesion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610 · cited 8×
“Several studies have shown no effect on levels of soluble VCAM-1, while one study reported an increase (Johansen et al. 1999) and one study reported that supplementation with a moderate dose of fish oil (1.2 g EPA + DHA/d) for 12 weeks decreased plasma levels of soluble VCAM-1 in older subjects, but did not have any e…”
BackgroundInfluentialThe Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart Disease
Kromhout, D., Bosschieter, E. B., & Coulander, C. D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121901 · Cited by 2,177 · cited 1×
“…that consumption of fish or long-chain n-3 PUFA found in oily fish and fish oils protects against CVD inWestern populations (Miettinen et al. 1982; Kromhout et al. 1985, 1995; Shekelle et al. 1985; Norell et al. 1986; Feskens et al. 1993; Siscovick et al. 1995; Daviglus et al. 1997; Albert et al.…”
BackgroundKliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164 · cited 1×
“…to be no distinction between the n-3 PUFA and the n-6 PUFA in their binding affinity and/ or activating capacity, and no relationship with chain length or number of double bonds (Forman et al. 1997; Kliewer et al. 1997; Krey et al. 1997; Lin et al. 1999; Wolfrum et al. 2001; Xu et al. 2001).”
BackgroundForman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
Yudkin, J. S., Kumari, M., Humphries, S. E., & Mohamed-Ali, V. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00463-3 · Cited by 1,775
Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb
Jiang, J., & Struhl, G. (1998) · Nature · doi:10.1038/35154 · Cited by 1,735
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692 · cited 1×
“…that the plasma level of CRP is a strong independent predictor of future myocardial infarction, stroke and pulmonary vascular disease among individuals without known CVD (Kuller et al. 1996; Tracy et al. 1997; Ridker et al. 1998, 2000; Koenig et al. 1999; Danesh et al. 2000; Mendall et al. 2000).”
Background
Cited by
Fish Oil Replacement and Alternative Lipid Sources in Aquaculture Feeds
(2010) · CRC Press eBooks · doi:10.1201/9781439808634 · Cited by 505
The relationship between the fatty acid composition of immune cells and their function
Calder, P. C. (2008) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.09.016 · Cited by 499
Immune modulation by parenteral lipid emulsions
Wanten, G. J., & Calder, P. C. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.5.1171 · Cited by 416
n -3 Fatty acids, inflammation and immunity: new mechanisms to explain old actions
Calder, P. C. (2013) · Proceedings of the Nutrition Society · doi:10.1017/s0029665113001031 · Cited by 364
Kiecolt-Glaser, J. K., Belury, M. A., Andridge, R., Malarkey, W. B., & Glaser, R. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.07.229 · Cited by 340
“…in postsurgical patients who receive enterally-delivered n-3 PUFAs vs. those who do not; although the salutary effects cannot be ascribed solely to the n-3 PUFAs because the supplements typically included other nutrients, the overall advantage is clear (Heyland et al., 2001; Yaqoob, 2004).”
Background
Metadata
- Authors
- Yaqoob, P.
- Venue
- Proceedings of the Nutrition Society
- Publisher
- Cambridge University Press (CUP)
- Published
- 2004-02
- Volume
- 63
- Issue
- 1
- Pages
- 89-105
- ISSN
- 0029-6651 (ISSN-L)
- 1475-2719
- OpenAlex
- W2164071126
- Cited by
- 139
- References
- 30
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fatty acids and the immune system: from basic science to clinical applications. https://app.cochat.ai/papers/10.1079/pns2003328
- The paper
- Yaqoob, P. (2004). Fatty acids and the immune system: from basic science to clinical applications. Proceedings of the Nutrition Society. https://doi.org/10.1079/pns2003328
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.